“Delivering value-added solutions through our core branded ingredients requires trusted partners who share our unwavering commitment to quality, innovation, and integrity. That’s why we are proud to partner with APD, a collaborator that exemplifies these values.
APD is helping Valensa raise the bar for clean, clinically backed bioactives and customer-centric innovation. ”
— Umasudhan Palaniswamy, President & CEO
Valensa is a global supplier of bioactive ingredients, including saw palmetto and astaxanthin. The company aims to set the gold standard for pure, proven, and powerful bioactive health ingredients that improve lives and promote wellness.
The Challenge
Valensa was looking for a partner who could help innovate in the bioactive ingredient space, especially by applying cyclodextrin inclusion technology. The company wanted a partner who could help support:
- R&D and mid-scale production work to increase the oil content of saw palmetto ingredients.
- Introducing the active ingredient in new forms, such as beverages, liquid shots, emulsions, and gummies, while minimizing the typical saw palmetto flavor.
APD’s Solution
APD utilized its expertise on cyclodextrin inclusion to develop formulations with saw palmetto and astaxanthin cyclodextrin inclusion at various oil loads and concentrations. Our range of spray drying services using the patented Dynamic Atomization Technology helped Valensa develop the most promising formulations and create a rapid path towards production.
Our Results
Through its partnership with APD, Valensa has been able to expand its flagship products successfully by offering them in convenient, consumer-preferred formats that align with evolving market demand.
Learn how Advanced Powder Dynamics supports your particle and powder engineering requirements. Contact us or call (928) 492-4040.
William West, a Harvard MBA, has a proven track record of scaling businesses, having expanded HID Global Corporation’s revenue from $200 million to $1 billion through strategic acquisitions. As Co-founder, CFO, and COO at ACRE, LLC, he transformed the company into a $350 million global leader. His vision now drives Tesseract Life Sciences’ mission to redefine health with science-backed innovations.
